This inventor holds 2 USPTO granted patents. Top assignee: The University of Texas System. Active years: 2002-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2006
Title: Michael Gotthardt: Innovator in LDL Receptor Signaling
Introduction
Michael Gotthardt is a prominent inventor based in Dallas, TX (US). He has made significant contributions to the field of biochemistry, particularly in the area of LDL receptor signaling. With a total of 2 patents, his work has the potential to impact medical research and therapeutic approaches.
Latest Patents
Michael Gotthardt's latest patents focus on LDL receptor signaling assays and pathways. The first patent provides methods and compositions for inducing and detecting signal transduction through LDL receptors. It specifically addresses the detection of stress that alters the functional interaction of low-density lipoprotein (LDL) receptor binding polypeptides with LDL receptor interaction domains. The methods involve introducing a predetermined stress into a system that facilitates the interaction of these polypeptides, allowing for the detection of stress-biased interactions. The binding polypeptides mentioned include SEMCAP-1, JIP-1, PSD-95, JIP-2, Talin, OMP25, CAPON, PIP4,5 kinase, Na channel brain 3, Mint1, ICAP-1, and APC subunit 10.
The second patent similarly provides methods and compositions for detecting signal transduction through LDL receptors. It emphasizes the introduction of stress into a system to observe the interactions between LDL receptor binding polypeptides and their respective interaction domains. This innovative approach aims to enhance the understanding of LDL receptor signaling pathways.
Career Highlights
Michael Gotthardt is affiliated with the University of Texas System, where he conducts his research and development. His work has garnered attention for its potential applications in understanding and treating conditions related to cholesterol metabolism and cardiovascular health.
Collaborations
One of his notable collaborators is Joachim Herz, with whom he has worked on various research projects related to LDL receptor signaling.
Conclusion
Michael Gotthardt's contributions to the field of LDL receptor signaling through his innovative patents highlight his role as a key inventor in biochemistry. His work continues to pave the way for advancements in medical research and therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile